143 related articles for article (PubMed ID: 9560835)
1. The genetics of ovarian cancer: molecular biology and clinical application.
DePasquale SE; Giordano A; Donnenfeld AE
Obstet Gynecol Surv; 1998 Apr; 53(4):248-56. PubMed ID: 9560835
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the molecular genetics of hereditary breast and ovarian cancer.
Lancaster JM; Wiseman RW
Prog Clin Biol Res; 1997; 396():31-51. PubMed ID: 9108588
[No Abstract] [Full Text] [Related]
3. Genetic testing by cancer site: ovary.
Weissman SM; Weiss SM; Newlin AC
Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
[TBL] [Abstract][Full Text] [Related]
4. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
[TBL] [Abstract][Full Text] [Related]
5. Hereditary and sporadic ovarian cancer: genetic testing and clinical implications (review).
Angioli R; Estape R; Mason M; Penalver M
Int J Oncol; 1998 May; 12(5):1029-34. PubMed ID: 9538124
[TBL] [Abstract][Full Text] [Related]
6. Cancer genetics for the clinician: recommendations on screening for BRCA1 and BRCA2 mutations.
Clark BA
Cleve Clin J Med; 2000 Jun; 67(6):408-15,. PubMed ID: 10860223
[TBL] [Abstract][Full Text] [Related]
7. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
[TBL] [Abstract][Full Text] [Related]
8. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing.
Rubin SC; Blackwood MA; Bandera C; Behbakht K; Benjamin I; Rebbeck TR; Boyd J
Am J Obstet Gynecol; 1998 Apr; 178(4):670-7. PubMed ID: 9579428
[TBL] [Abstract][Full Text] [Related]
9. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
Lu KH
Fam Cancer; 2008; 7(1):53-8. PubMed ID: 17636427
[TBL] [Abstract][Full Text] [Related]
10. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
Shulman LP
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
[TBL] [Abstract][Full Text] [Related]
11. Hereditary ovarian cancer.
Langston AA; Ostrander EA
Curr Opin Obstet Gynecol; 1997 Feb; 9(1):3-7. PubMed ID: 9090474
[TBL] [Abstract][Full Text] [Related]
12. Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient.
Njoroge SW; Burgess KR; Cobleigh MA; Alnajar HH; Gattuso P; Usha L
Breast Cancer Res Treat; 2017 Nov; 166(1):315-319. PubMed ID: 28702897
[TBL] [Abstract][Full Text] [Related]
13. Genetics and ovarian carcinoma.
Lynch HT; Casey MJ; Lynch J; White TE; Godwin AK
Semin Oncol; 1998 Jun; 25(3):265-80. PubMed ID: 9633840
[TBL] [Abstract][Full Text] [Related]
14. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.
Geirdal AØ; Reichelt JG; Dahl AA; Heimdal K; Maehle L; Stormorken A; Møller P
Fam Cancer; 2005; 4(2):121-6. PubMed ID: 15951962
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
16. [Clinical counseling and care of women with genetic predisposition to breast and ovarian carcinoma].
Schmutzler RK; Kempe A; Kiechle M; Beckmann MW
Dtsch Med Wochenschr; 1999 May; 124(18):563-6. PubMed ID: 10356583
[No Abstract] [Full Text] [Related]
17. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
18. Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.
Taylor N; Mutch DG
Oncology (Williston Park); 2006 Jan; 20(1):85-94; discussion 94-6, 100. PubMed ID: 16572595
[TBL] [Abstract][Full Text] [Related]
19. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
[TBL] [Abstract][Full Text] [Related]
20. Screening and prevention of hereditary gynecologic cancers.
Kehoe SM; Kauff ND
Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
